https://www.selleckchem.com/pr....oducts/gf109203x.htm
There were two mild unanticipated adverse events definitely related to the device. The safety and efficacy of the iTEAR device observed in this study support its indication for treating DED. Neurostimulation has the potential to improve signs and symptoms of DED. Neurostimulation has the potential to improve signs and symptoms of DED. To investigate intereye associations of visual field (VF) defects. We selected 24-2 VF pairs of both eyes from 63,604 patients tested on the same date with mean deviation (MD) ≥ -12 dB. VFs were decompos
Like
Comment
Share
